Radio and PodcastLive Radio & Podcasts
Science & Medicine
Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth
Synopsis: At a moment when biotech is rethinking growth, innovation, and patient impact, Alok Tayi sits down with Christophe Bourdon, Chief Executive Officer of LEO Pharma, to explore what it truly means to build a purpo...
About This Episode
Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth is an episode from Biotech 2050 Podcast by Biotech2050 Podcast. Synopsis: At a moment when biotech is rethinking growth, innovation, and patient i...
Podcast
This episode belongs to Biotech 2050 Podcast.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jan 20, 2026, 00:13:02 long, audio available.
Related Episodes
Continue listening to more episodes from Biotech 2050 Podcast.
Ardelyx Leaders Mike Raab & Laura Williams on Building Biotech Around Patients
Jun 10, 2026 - 00:41:21
Acadia CEO Catherine Owen Adams on Neurodegeneration, AI & Building Biotech Vision
May 13, 2026 - 00:33:34
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
Apr 16, 2026 - 00:23:07
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
Mar 6, 2026 - 00:14:16
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
Feb 11, 2026 - 00:25:06
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
Feb 10, 2026 - 00:26:40